AzTrials
AzTrials

Soft Contact LensesNCT07290829

Conformity of Conjunctival Hyperemia Assessment in Soft Contact Lens Wearers Using Image J Analysis and Efron Degree System

A study testing hydrogel soft contact lens in people with Soft Contact Lenses, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Soft Contact Lens (SCL) use all over the world is still increasing. Ocular surface inflammatory reaction is the most common risk of using SCL. Currently, the standard used to assess this complication is the Efron Degree System (EDS), but it has high variability due its subjectivity. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Soft Contact Lenses
What is being tested?
hydrogel soft contact lens
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteIndonesia
Study dates
28 Mar 2019to 28 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • subject with mild to moderate myopia (-0.50 to -6.00 D)
  • age between 18-45 years old
  • subject who refuse refractive correction with glasses or surgery
  • patient with astigmatism refractive error no more than -1 Diopter

Who cannot join

  • subject with previous intraocular surgery
  • subject who is wearing SCL continuously
  • subject with history of dry eyes, uveitis, glaucoma, or corneal and conjunctival disorders
  • subject with history of allergic reaction to contact lens material or lens wetting solution used in this study
  • subject with ongoing eye drop treatment
  • female subject with ongoing pregnancy or on breastfeeding
  • subject with too improper lens fitting
  • subject who work around exposure of chemical substance, smoke, hazardous gas, or fire sparks

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Department of Ophthalmology, Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital, Indonesia

    Jakarta, DKI Jakarta, 10320

Other trials in Indonesia

About this study

Soft Contact Lens (SCL) use all over the world is still increasing. Ocular surface inflammatory reaction is the most common risk of using SCL. Currently, the standard used to assess this complication is the Efron Degree System (EDS), but it has high variability due its subjectivity. ImageJ gives more objective result with conjunctival vasodilation and vascular density assessment, so that complication management can be given earlier.

Purpose: Evaluate the suitability of SDE with ImageJ analysis in assessing conjunctival hyperemia in SCL use within 2 weeks.

Read the detailed description

This is a paired prospective analytic study. Subjects with myopia who have not used SCL routinely before were instructed to use SCL for 14 days. Conjunctival inflammation were assessed with slit lamp examination before, at day 7, and day 14 of using SCL. Slit lamp pictures were analysed with EDS and ImageJ to be compared.

Being tested
hydrogel soft contact lens
Keywords
soft contact lens, conjunctival hyperemia, image J analysis, efron degree system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hydrogel soft contact lensDevice

    This study aim to analyze the conformity of hyperemia when evaluated by ophthalmologist using the Efron degree system compared to evaluation by a computerized model (Image J analysis )

Study groups in NCT07290829
Study groupRoleWhat they receive
Hyperemia evaluation of soft contact lens wearerExperimentalHyperemia evaluation of soft contact lens wearer on day 0 (before using SCL), day 7, and day 14 of wearing SCL
Receives: Device: hydrogel soft contact lens

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efron degree system for hyperemia degree

    Hyperemia grade based on Efron degree system, identified by percentage of hyperemia on the bulbar dan limbal conjunctiva

    • Normal
    • Trace
    • Mild
    • Moderate
    • Severe

    Measured: on day 0 (before using SCL), day 7, and day 14

  2. Image J analysis of hyperemia degree

    Vascular density (%area) and Vascular diameter (μm )

    Measured: on day 0 (before using SCL), day 7, and day 14

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2025
  2. Study start28 Mar 2019
  3. Primary completion28 Jan 2025
  4. Study completion28 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07290829
Sponsor's protocol ID
19-02-0138
Other IDs
Faculty of Medicine, Universit
Status last verified
Dec 2025
First submitted
6 Dec 2025
Last updated
18 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: IPD will not be shared due to patient privacy considerations

Questions about this trial

What is this clinical trial studying?

A study testing hydrogel soft contact lens in people with Soft Contact Lenses, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efron degree system for hyperemia degree (time frame: on day 0 (before using SCL), day 7, and day 14). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in